Phase I Study of the Farnesyl Transferase Inhibitor R115777 (NSC 702818) [tipifarnib] in Patients With Myelodysplastic Syndrome
Phase of Trial: Phase I
Latest Information Update: 13 Dec 2013
At a glance
- Drugs Tipifarnib (Primary)
- Indications Myelodysplastic syndromes
- Focus Adverse reactions; Therapeutic Use
- 01 Jul 2013 Status changed from suspended to completed as reported by ClinicalTrials.gov.
- 21 Jan 2013 Status changed from completed to suspended as reported by ClinicalTrials.gov.
- 06 Aug 2007 Status changed from suspended to completed.